The store will not work correctly when cookies are disabled.
5-(2,3-dichlorophenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine
ID: ALA4570428
PubChem CID: 82556507
Max Phase: Preclinical
Molecular Formula: C12H8Cl2N4
Molecular Weight: 279.13
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1nc2cccc(-c3cccc(Cl)c3Cl)n2n1
Standard InChI: InChI=1S/C12H8Cl2N4/c13-8-4-1-3-7(11(8)14)9-5-2-6-10-16-12(15)17-18(9)10/h1-6H,(H2,15,17)
Standard InChI Key: JFVBFJXXXHHBSP-UHFFFAOYSA-N
Molfile:
RDKit 2D
18 20 0 0 0 0 0 0 0 0999 V2000
11.6261 -12.1656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3358 -11.7562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3330 -10.9335 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6243 -10.5283 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9181 -11.7567 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.9147 -10.9356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1328 -10.6850 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6529 -11.3513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1382 -12.0135 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.8323 -11.3458 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6278 -12.9806 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9184 -13.3885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9178 -14.2049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6260 -14.6145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3361 -14.2017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3332 -13.3866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0399 -12.9762 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
13.0452 -14.6079 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 5 1 0
8 10 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
1 11 1 0
16 17 1 0
15 18 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 279.13 | Molecular Weight (Monoisotopic): 278.0126 | AlogP: 3.29 | #Rotatable Bonds: 1 |
Polar Surface Area: 56.21 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 2.67 | CX LogP: 3.79 | CX LogD: 3.79 |
Aromatic Rings: 3 | Heavy Atoms: 18 | QED Weighted: 0.74 | Np Likeness Score: -1.73 |
References
1. Farand J, Kropf JE, Blomgren P, Xu J, Schmitt AC, Newby ZE, Wang T, Murakami E, Barauskas O, Sudhamsu J, Feng JY, Niedziela-Majka A, Schultz BE, Schwartz K, Viatchenko-Karpinski S, Kornyeyev D, Kashishian A, Fan P, Chen X, Lansdon EB, Ports MO, Currie KS, Watkins WJ, Notte GT.. (2020) Discovery of Potent and Selective MTH1 Inhibitors for Oncology: Enabling Rapid Target (In)Validation., 11 (3): [PMID:32184970] [10.1021/acsmedchemlett.9b00420] |